Conquering Diseases

Study Of An Investigational Drug Combination Before And Following Surgery For Melanoma

Description

Seeking adults with Stage III or IV melanoma skin cancer that will be treated with surgery for a study of an investigational drug combination.

Overview

Participants in this study will be randomly assigned to get either the usual immunotherapy treatment or the investigational drug combination prior to and following melanoma removal surgery. The drugs are given as an IV infusion on 3-week cycles for 18 cycles starting 9 weeks before surgery and ending after about a year.

What we're hoping for

We are studying whether an investigational drug combination is better, worse or the same as the usual immunotherapy before and following surgery for Stage III or IV melanoma skin cancer.

Additional Information

ClinicalTrials.gov Identifier: NCT06190951

 Principal Investigator

Tasneem  Ali, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989